Meryx


Public list: Pharma Startups (4729) Cancer Therapeutics (1132)

Meryx develops novel Mer tyrosine kinase inhibitor therapeutics for critically ill patients in areas of cancer and other major unmet diseases.

Meryx develops novel Mer tyrosine kinase inhibitor therapeutics for critically ill patients in areas of cancer and other major unmet diseases.

Company (Alive / Active)

Phone: 919-843-5486

Fax:

130 Mason Farm Rd
Suite 3100A
Chapel Hill, 27599
North Carolina, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Meryx $7.1M Jun 29, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Meryx Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors

Board Members

There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)